(Q40617049)

22 September 2017

title

Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine (English)

1 reference

22 September 2017

1 reference

M Gangar

1

1 reference

22 September 2017

G Arias

series ordinal

2

1 reference

22 September 2017

J G O'Brien

series ordinal

3

1 reference

22 September 2017

C A Kemper

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Annals of Pharmacotherapy

22 September 2017

published in

1 reference

22 September 2017

volume

34

1 reference

22 September 2017

issue

7-8

1 reference

22 September 2017

page(s)

839-842

1 reference

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

22 September 2017

cites work

1 reference

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication

21 January 2018

1 reference

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19258

1 reference

22 September 2017

1 reference